Related references
Note: Only part of the references are listed.Efficient Presentation of Soluble Antigen by Cultured Human Dendritic Cells Is Maintained by Granulocyte/Macrophage Colony-stimulating Factor Plus Interleukin 4 and Downregulated by Tumor Necrosis Factor α
Federica Sallusto et al.
JOURNAL OF IMMUNOLOGY (2018)
A Temporal Proteomic Map of Epstein-Barr Virus Lytic Replication in B Cells
Ina Ersing et al.
CELL REPORTS (2017)
The impact of HLA class I and EBV latency-II antigen-specific CD8+ T cells on the pathogenesis of EBV+ Hodgkin lymphoma
K. Jones et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2016)
Differential uptake and cross-presentation of soluble and necrotic cell antigen by human DC subsets
Meng-Chieh Chiang et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2016)
The Missing Link in Epstein-Barr Virus Immune Evasion: the BDLF3 Gene Induces Ubiquitination and Downregulation of Major Histocompatibility Complex Class I (MHC-I) and MHC-II
Laura L. Quinn et al.
JOURNAL OF VIROLOGY (2016)
Intrathecal CD8 T-cells of multiple sclerosis patients recognize lytic Epstein-Barr virus proteins
Gijsbert P. van Nierop et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Intrathecal CD8 T-cells of multiple sclerosis patients recognize lytic Epstein-Barr virus proteins
Gijsbert P. van Nierop et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Dendritic cell maturation and cross-presentation: timing matters!
Andres Alloatti et al.
IMMUNOLOGICAL REVIEWS (2016)
The Epstein-Barr Virus Glycoprotein gp150 Forms an Immune-Evasive Glycan Shield at the Surface of Infected Cells
Anna M. Gram et al.
PLOS PATHOGENS (2016)
Early T Cell Recognition of B Cells following Epstein-Barr Virus Infection: Identifying Potential Targets for Prophylactic Vaccination
Jill M. Brooks et al.
PLOS PATHOGENS (2016)
The immunology of Epstein-Barr Virus Induced Disease
Graham S. Taylor et al.
ANNUAL REVIEW OF IMMUNOLOGY VOL 33 (2015)
Latent Expression of the Epstein-Barr Virus (EBV)-Encoded Major Histocompatibility Complex Class I TAP Inhibitor, BNLF2a, in EBV-Positive Gastric Carcinomas
Michael J. Strong et al.
JOURNAL OF VIROLOGY (2015)
Unexpected patterns of Epstein-Barr virus transcription revealed by a High throughput PCR array for absolute quantification of viral mRNA
Rosemary J. Tierney et al.
VIROLOGY (2015)
Comprehensive Analysis of the Naturally Processed Peptide Repertoire: Differences between HLA-A and B in the Immunopeptidome
Ingrid M. M. Schellens et al.
PLOS ONE (2015)
Cooperation between Epstein-Barr Virus Immune Evasion Proteins Spreads Protection from CD8+ T Cell Recognition across All Three Phases of the Lytic Cycle
Laura L. Quinn et al.
PLOS PATHOGENS (2014)
CD8+ T Cell Responses to Lytic EBV Infection: Late Antigen Specificities as Subdominant Components of the Total Response
Rachel J. M. Abbott et al.
JOURNAL OF IMMUNOLOGY (2013)
EBV BILF1 Evolved To Downregulate Cell Surface Display of a Wide Range of HLA Class I Molecules through Their Cytoplasmic Tail
Bryan D. Griffin et al.
JOURNAL OF IMMUNOLOGY (2013)
Cross-presentation and genome-wide screening reveal candidate T cells antigens for a herpes simplex virus type 1 vaccine
Lichen Jing et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
T-cell therapy in the treatment of post-transplant lymphoproliferative disease
Catherine M. Bollard et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
HLA Associations in Classical Hodgkin Lymphoma: EBV Status Matters
Xin Huang et al.
PLOS ONE (2012)
EBV Protein BNLF2a Exploits Host Tail-Anchored Protein Integration Machinery To Inhibit TAP
Danielle Horst et al.
JOURNAL OF IMMUNOLOGY (2011)
The Epstein-Barr Virus-Encoded BILF1 Protein Modulates Immune Recognition of Endogenously Processed Antigen by Targeting Major Histocompatibility Complex Class I Molecules Trafficking on both the Exocytic and Endocytic Pathways
Jianmin Zuo et al.
JOURNAL OF VIROLOGY (2011)
Persistent Infection Drives the Development of CD8+ T Cells Specific for Late Lytic Infection Antigens in Lymphocryptovirus-Infected Macaques and Epstein-Barr Virus-Infected Humans
Nina Orlova et al.
JOURNAL OF VIROLOGY (2011)
EBV Tegument Protein BNRF1 Disrupts DAXX-ATRX to Activate Viral Early Gene Transcription
Kevin Tsai et al.
PLOS PATHOGENS (2011)
Uncovering the interplay between CD8, CD4 and antibody responses to complex pathogens
Magdalini Moutaftsi et al.
FUTURE MICROBIOLOGY (2010)
HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell response in EBV-related Hodgkin lymphoma
Henrik Hjalgrim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The Epstein-Barr Virus G-Protein-Coupled Receptor Contributes to Immune Evasion by Targeting MHC Class I Molecules for Degradation
Jianmin Zuo et al.
PLOS PATHOGENS (2009)
Stage-Specific Inhibition of MHC Class I Presentation by the Epstein-Barr Virus BNLF2a Protein during Virus Lytic Cycle
Nathan P. Croft et al.
PLOS PATHOGENS (2009)
The Dynamics of EBV Shedding Implicate a Central Role for Epithelial Cells in Amplifying Viral Output
Vey Hadinoto et al.
PLOS PATHOGENS (2009)
A mechanism for the HLA-A*01-associated risk for EBV+ Hodgkin lymphoma and infectious mononucleosis
Rebekah M. Brennan et al.
BLOOD (2008)
The CD8 T-Cell Response against Murine Gammaherpesvirus 68 Is Directed toward a Broad Repertoire of Epitopes from both Early and Late Antigens
Sara Gredmark-Russ et al.
JOURNAL OF VIROLOGY (2008)
HLA-A*02 is associated with a reduced risk and HLA-A*01 with an increased risk of developing EBVI Hodgkin lymphoma
Marijke Niens et al.
BLOOD (2007)
A CD8+ T cell immune evasion protein specific to Epstein-Barr virus and its close relatives in Old World primates
Andrew D. Hislop et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Viral interference with antigen presentation does not alter acute or chronic CD8 T cell immunodominance in murine cytomegalovirus infection
Michael W. Munks et al.
JOURNAL OF IMMUNOLOGY (2007)
Immunodominant tuberculosis CD8 antigens preferentially restricted by HLA-B
Deborah A. Lewinsohn et al.
PLOS PATHOGENS (2007)
Control of Epstein-Barr virus infection in vitro by T helper cells specific for virion glycoproteins
D Adhikary et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Impact of HLA-B alleles, epitope binding affinity, functional avidity, and viral coinfection on the immunodominance of virus-specific CTL responses
Florian Bihl et al.
JOURNAL OF IMMUNOLOGY (2006)
Genome-wide analysis reveals a highly diverse CD8 T cell response to murine cytomegalovirus
Michael W. Munks et al.
JOURNAL OF IMMUNOLOGY (2006)
Differential targeting and shifts in the immunodominance of Epstein-Barr virus-specific CD8 and CD4 T cell responses during acute and persistent infection
T Woodberry et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Epstein-Barr virus lytic infection contributes to lymphoproliferative disease in a SCID mouse model
GK Hong et al.
JOURNAL OF VIROLOGY (2005)
Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects
AW Sylwester et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Tonsillar homing of Epstein-Barr virus-specific CD8+ T cells and the virus-host balance
AD Hislop et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells
G Napolitani et al.
NATURE IMMUNOLOGY (2005)
CD8+ immunodominance among Epstein-Barr virus lytic cycle antigens directly reflects the efficiency of antigen presentation in lytically infected cells
VA Pudney et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA
P Kiepiela et al.
NATURE (2004)
Proteins of purified Epstein-Barr virus
E Johannsen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Epitope-specific evolution of human CD8+ T cell responses from primary to persistent phases of Epstein-Barr virus infection
AD Hislop et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
EBV-Specific CD8+ T cell memory:: Relationships between epitope specificity, cell phenotype, and immediate effector function
AD Hislop et al.
JOURNAL OF IMMUNOLOGY (2001)
Cell-associated ovalbumin is cross-presented much more efficiently than soluble ovalbumin in vivo
M Li et al.
JOURNAL OF IMMUNOLOGY (2001)
The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators
R Feederle et al.
EMBO JOURNAL (2000)
Share Paper
